Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Isidoro Horwitz"'
Publikováno v:
The Pediatric Infectious Disease Journal. 17:S139-S148
Objective. To determine the burden of Haemophilus influenzae type b (Hib) disease, the safety and immunogenicity of Hib conjugate vaccine, the practicality of combining Hib conjugate and diphtheria-tetanuspertussis vaccines and the effectiveness of r
Autor:
Isidoro Horwitz, J Toro, Rosanna Lagos, Myron M. Levine, Paulina Abrego, Steven S. Wasserman, O. San Martin, Orin S. Levine, C Bustamante
Publikováno v:
The Pediatric Infectious Disease Journal. 15:216-222
Background. Haemophilus influenzae type b (Hib) conjugate vaccines have demonstrated an impressive impact in diminishing Hib disease in industrialized countries. However, their high cost prompts nonindustrialized countries to corroborate their effect
Autor:
F. Olivari, J. Glenn Morris, J. P. Dattas, M. Jeanette Jones, Susan K. Hoiseth, David R. Maneval, James M. Musser, Isidoro Horwitz, Nancy Enríquez, Alfredo Avendano, Myron M. Levine, Ingeborg Prenzel, S. Topelberg, Rosanna Lagos
Publikováno v:
Journal of Infectious Diseases. 164:1149-1153
Thirty-six consecutive patients with invasive Haemophilus influenzae type b (Hib) infections at Roberto del Rio Children's Hospital, Santiago, Chile, were enrolled in a prospective study. Throat cultures were obtained from household contacts of each
Autor:
Alfredo Avendano, Isidoro Horwitz, Catterine Ferreccio, Rosanna Lagos, Marisol Cayazzo, Bernard Fritzell, Carlton Meschievitz, Myron M. Levine
Publikováno v:
The Pediatric infectious disease journal. 12(8)
The safety and immunogenicity of a vaccine against Haemophilus influenzae type b consisting of purified polyribosylribitol phosphate conjugated to tetanus toxoid (PRP-T) were evaluated in 277 Chilean infants who were randomly assigned to one of three
Autor:
Marisol Cayazzo, C. Flores, Catterine Ferreccio, Isidoro Horwitz, L. Avila, Bernard Fritzell, John D. Clemens, Alfredo Avendano, Myron M. Levine, Michel Cadoz
Publikováno v:
The Pediatric infectious disease journal. 10(10)
The safety and immunogenicity of a vaccine against Haemophilus influenzae type b consisting of purified polyribosylribitolphosphate conjugated to tetanus toxoid (PRP-T) was evaluated in 278 Chilean infants who were randomly assigned to one of three t
Autor:
Myron M. Levine, Bernard Fritzell, Isidoro Horwitz, John D. Clemens, Catterine Ferreccio, Malla R. Rao, Kathryn M. Edwards
Publikováno v:
JAMA: The Journal of the American Medical Association. 267:673
Objective. —To assess whether serum antibody responses to diphtheriatetanus-pertussis (DTP) vaccine were affected by coadministration ofHaemophilus influenzaetype b capsular polyribosylribitol phosphate polysaccharide-tetanus protein (PRP-T) conjug
Publikováno v:
Pediatrics. 38:1003-1008
The thyroid response to TSH was studied in a group of 16 infants with severe marasmus and 9 normal controls of the same age. The radioiodine uptake, the BEI, and the oxygen consumption were determined in both groups before and after the administratio
Publikováno v:
Pediatrics. 33:554-561
Oxygen consumption was determined with a closed circuit apparatus in 52 normal infants and 22 marasmatic infants. Oxygen consumption in marasmatic infants was similar to that of the normal ones when expressed in relation to the actual weight, but was
Autor:
Myron L. Levine, Claudia Lanata, Patricia Herrera, Isidoro Horwitz, Alfredo Avendano, Euana Duarte, Ingebord Prenzel
Publikováno v:
The Journal of infectious diseases. 153(2)
doll MS. Prevalence of serum antibody to staphylococcal enterotoxin F among Wisconsin residents: implications for toxic shock syndrome. J Infect Dis 1983;148:692-8 15. Vergeront JM, Blouse LE, Crass BA, Stolz SJ, Bergdoll MS, Davis JP. Regional diffe
Publikováno v:
Revista chilena de pediatría v.57 n.2 1986
SciELO Chile
CONICYT Chile
instacron:CONICYT
SciELO Chile
CONICYT Chile
instacron:CONICYT
19 patients of both sexes, aged 9.3 i 3.0 (X ± S.D.) years with bacteriologically confirmed typhoid orparatyphoid B fever were enrolled in this study and distributed in two treatment groups: Patients of Group I(N —1.1) received Cloramphenicol (CAP